e-learning
resources
Vienna 2009
Monday, 14.09.2009
Translational research/biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No evidence of corticosteroid resistance in COPD alveolar macrophages
J. Plumb, L. Robinson, A. Bizzi, F. Facchinetti, R. Patacchini, D. Singh (Manchester, United Kingdom; Parma, Italy)
Source:
Annual Congress 2009 - Translational research/biomarkers
Session:
Translational research/biomarkers
Session type:
E-Communication Session
Number:
2928
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Plumb, L. Robinson, A. Bizzi, F. Facchinetti, R. Patacchini, D. Singh (Manchester, United Kingdom; Parma, Italy). No evidence of corticosteroid resistance in COPD alveolar macrophages. Eur Respir J 2009; 34: Suppl. 53, 2928
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Phenotype polarization of alveolar macrophages in COPD patients
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
The lung microbiota changes associated with inhaled corticosteroid and azithromycin in murine model of COPD
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
IFNγ induces steroid unresponsiveness in smokers alveolar macrophages
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Expression of MMP-8 protein in alveolar macrophages is related to bronchial asthma severity and treatment efficacy
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
M2 polarized alveolar macrophages in pulmonary fibrosis
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007
IL-33 and airway remodelling in paediatric severe therapy resistant asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept